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serum in the blood-samples are expressed as counts per unit
time. These expressions of quantity are then used to find
the occupancy in the same way as if they were (Jt.g.
Optimal Daily Dosage
Total Dosage
The total daily dosage required to maintain the
desired optimal average serum-level is found using
occupancy in the formula:
The equation is an expression of the occupancy
principle in a form suitable for the pharmacological
problem. The principle has a general validity, but the
use of the method described above to measure occu-
pancy requires that a dose of a drug should be absorbed
and disappear in the same manner whether it is given
as a first dose or after the blood-level has reached an
equilibrium value. Exceptions to this condition are
rare. 7
Interval between Doses
More attention should be paid to the interval
between administrations of the drug. If the drug to be
used is an antibiotic, the minimum desired level will be
the minimum inhibitory concentration (M.iC.) of the
drug for the organism, and the maximum level should
be below the known toxic serum-level of the drug. If
this minimum is half the maximum, then the time
interval between doses should not be greater than the
time taken for the serum concentration after a test dose
to fall to half of its maximum. The desired average
level will lie approximately midway between the
desired minimum and maximum.
For example, if the M.i.c. of kanamycin for a particu-
lar organism is 4 g. per ml. and the toxic level is
16 g. per ml. the intention might be to keep between
12 and 6 g. per ml. Using the example shown in fig. 4
the maximum concentration after the test dose is
26 g. per ml. and the concentration has fallen to
13 ;jLg. per ml. after 12 hours. Therefore a 12-hour
interval between administrations is appropriate in this
case. The desired average level would then be 9 .g.
per ml. requiring a total daily dosage of 225 mg.
When administration is by constant infusion, such
as with cytotoxic drugs, the serum-level attained
should be constant and will equal the desired level.
Conclusion
The problem of toxic drug accumulation in
pharmacotherapeutics is a serious one, and the need for
a theory of drug accumulation which can be used by
the practising physician has been emphasised before. 8
The approach described here is formally correct
irrespective of the method of administration, and is
presented in a formulation designed for simple everyday
use.
The concept of occupancy and the occupancy
principle have been applied to studies of the kinetics of
a wide variety of metabolic problems. These include
iodize, thyroid hormones,lo calcium absorption and
accretion, iron, bromine, trace elements, and radiation
dose from ingested isotopes.ll This application to
pharmacology forms a junction between one of the
diverse developments stemming from the occupancy
principle and the successful application of pharmaco-
kinetics to the analysis and solution of problems in
pharmacotherapeutics.
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Summary 
The effects of atropine 0.6 mg. intra-
venously administered to ten healthy
volunteers in recumbent position, on arterial pH,
PaCO2, and PaO2 were determined; there were no
significant alterations of blood gas values after atropine
administration. There seems to be no contraindication
to the use of atropine sulphate for premedication in
terms of its effect upon arterial blood-gases, in patients
with normal cardiorespiratory function.
Introduction
IN 1964, Tomlin et al.1 reported a finding that would
potentially limit the use of atropine. They presented
data which showed a fall in Pa02 after intramuscular
atropine.
We have evaluated the effects of intravenous
atropine sulphate on arterial blood gases in healthy
volunteers.
Method
The nine volunteers were healthy adult students between
the ages of 21 and 29 (mean 25). They ranged in height
from 64 to 73’5 in. with a mean of 69 in., and weighed from
115 to 210 lb. (mean 154 lb.). Three were female. All
consented to the administration of atropine and to arterial
puncture. The volunteers were recumbent during the tests.
Blood-samples were obtained via an indwelling Riley
needle inserted into the left brachial artery. Pao2 was
determined polarographically, using a Radiometer-Clark
electrode. pH was determined using a Radiometer glass
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10 Results for eight volunteers only; one sample was contaminated.
electrode with carbon-dioxide tensions being interpolated
by the Siggaard Anderson method.
Lead n of the electrocardiograph was monitored during
the procedure in eight volunteers.
After insertion of the intra-arte1&Iacute;al needle and the start of
an intravenous infusion of 5% glucose and 0’2% sodium
chloride a period of rest was allowed. Two arterial samples
were then drawn at 10-minute intervals.
Atropine sulphate 0’6 mg. was given intravenously in a
volume of 20 ml. and over a period of 2 minutes, and blood-
samples were drawn at intervals of 5, 15, 30, 45, and 60
minutes. Volunteers were then asked to take a maximum
inspiration three times during a 1-minute period. 5
minutes later, a final arterial sample was drawn.
Results
Pa02 levels did not change significantly at any time
during the monitoring period, and P aco2levels remained
within physiological limits throughout the test (see
figure and table). Variations in pH were not
significant (see table).
There were no arrhythmias associated with atropine
administration in any volunteer. Pulse-rate ranged
from a mean of 85 just before administration of the
drug to a mean of 103 afterwards; these changes were
not felt to be of clinical significance.
Discussion
In attempting to reconcile our results with those of
Tomlin et a1.1 some comments on their study should be
made:
(1) We used healthy volunteers while Tomlin et al.
investigated patients preoperatively.
(2) Tomlin et al. took no control samples before adminis-
tration of atropine, so they did not, in fact, demonstrate a
fall in Pao2 in any patient after the drug. All they did
demonstrate was a difference in Pa02 between two groups
of patients immediately before induction of general
anaesthesia, one group having received atropine.
(3) Three of their control patients had Pa02 levels above
102 mm. Hg, one being as high as 111’9 mm. Hg. These
are somewhat difficult to reconcile in a patient breathing
room air.
Our results are corroborated by Daly et al.2 who
found no fall in Pa02 in healthy volunteers after intra-
muscular administration of atropine sulphate.
Atropine sulphate given intravenously does not seem
to produce changes in blood gases in healthy volunteers.
We conclude that no contraindication to atropine as an
adjunct to premedication exists in so far as its effect on
arterial oxygenation is concerned. Additional studies
in patients with cardiopulmonary problems are
needed.
We thank Carol Haack and Nancy Bassett for their help in this
work.
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Summary 
A study of an antibiotic virgin popula-
tion in the Solomon Islands showed
that R factors can be recovered at low frequency under
natural conditions without the selective force of anti-
microbial drugs. These R factors were recovered from
soil and stool specimens, mediated resistance to
streptomycin and tetracycline, and, like certain R
factors recovered in the United States, inactivated
streptomycin by phosphorylation.
INTRODUCTION
DESPITE the worldwide distribution of resistance
(R) factors, the origin of these episomes remains
